Annual ROE
-51.39%
+7.68%+13.00%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual return on equity is currently -51.39%, with the most recent change of +7.68% (+13.00%) on 31 December 2023. During the last 3 years, it has fallen by -24.56% (-91.54%). PRLD annual ROE is now -179.44% below its all-time high of 64.69%, reached on 31 December 2018.PRLD ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-66.88%
-7.06%-11.80%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly return on equity is currently -66.88%, with the most recent change of -7.06% (-11.80%) on 30 September 2024. Over the past year, it has dropped by -12.97% (-24.06%). PRLD quarterly ROE is now -205.32% below its all-time high of 63.50%, reached on 30 June 2020.PRLD Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.0% | -24.1% |
| 3 y3 years | -91.5% | -107.0% |
| 5 y5 years | -179.4% | - |
PRLD ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -91.5% | +13.0% | -107.0% | at low |
| 5 y | 5 years | -179.4% | +13.0% | -205.3% | +48.8% |
| alltime | all time | -179.4% | +13.0% | -205.3% | +48.8% |
Prelude Therapeutics Incorporated ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -66.88%(+11.8%) |
| June 2024 | - | -59.82%(+13.0%) |
| Mar 2024 | - | -52.96%(-0.8%) |
| Dec 2023 | -51.39%(-13.0%) | -53.39%(-1.0%) |
| Sept 2023 | - | -53.91%(-1.9%) |
| June 2023 | - | -54.93%(+0.1%) |
| Mar 2023 | - | -54.86%(+8.8%) |
| Dec 2022 | -59.07% | -50.44%(+6.0%) |
| Sept 2022 | - | -47.57%(+8.7%) |
| June 2022 | - | -43.78%(+9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -40.18%(+15.8%) |
| Dec 2021 | -39.07%(+45.6%) | -34.69%(+7.4%) |
| Sept 2021 | - | -32.31%(+8.6%) |
| June 2021 | - | -29.76%(-21.2%) |
| Mar 2021 | - | -37.77%(-17.9%) |
| Dec 2020 | -26.83%(-148.1%) | -46.01%(-64.8%) |
| Sept 2020 | - | -130.63%(-305.7%) |
| June 2020 | - | 63.50%(+19.4%) |
| Mar 2020 | - | 53.19%(+56.7%) |
| Dec 2019 | 55.80%(-13.7%) | 33.95% |
| Dec 2018 | 64.69% | - |
FAQ
- What is Prelude Therapeutics Incorporated annual return on equity?
- What is the all time high annual ROE for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual ROE year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly return on equity?
- What is the all time high quarterly ROE for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly ROE year-on-year change?
What is Prelude Therapeutics Incorporated annual return on equity?
The current annual ROE of PRLD is -51.39%
What is the all time high annual ROE for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual return on equity is 64.69%
What is Prelude Therapeutics Incorporated annual ROE year-on-year change?
Over the past year, PRLD annual return on equity has changed by +7.68% (+13.00%)
What is Prelude Therapeutics Incorporated quarterly return on equity?
The current quarterly ROE of PRLD is -66.88%
What is the all time high quarterly ROE for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly return on equity is 63.50%
What is Prelude Therapeutics Incorporated quarterly ROE year-on-year change?
Over the past year, PRLD quarterly return on equity has changed by -12.97% (-24.06%)